3SPAGNOLO P,MAHER T M,RICHELDI L. Idiopathic? pulmonary fibrosis:Recent advances on pharmacological therapy[ J ]. Pharmacol Ther,2015,152:18-27.
4LOOMIS-KING H, FLAHERTY KR, MOORE BB. Pathogenesis, current treatments and future directions for idio- pathic pulmonary fibrosis [ J ]. Curt Opin Pharmacol, 2013, 13 (3): 377-385.
5WUYTS WA, AGOSTINI C, ANTONIOU KM, et al. The pathogenesis of pulmonary fibrosis: a moving target[J]. Eur Respir J, 2013, 41 (5): 1207- 1218.
6DELLA LATYA V,CECCHETrINI A,DEL RY S,et al. Bleomycin in the setting of lung fibrosis induction: From bi- ological mechanisms to counteractions [ J ]. Pharmacol Res, 2015, 97:122- 130.
7MOURATIS M A, AIDINIS V. Modeling pulmonary fibrosis with bleomycin [J]. Curr Opin Pulm Med,2011,17 (5): 355-61.
8WILLIAMSON J D,SADOFSKY L R,HART S P. The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis [J]. Exp Lung Res,2015, 41(2):57-73.
